Clinical Trials Directory

Trials / Completed

CompletedNCT01992146

Effect of High-dose Naloxone Infusion on Pain and Hyperalgesia in Patients Following Groin-Hernia Repair.

Effect of High-dose Naloxone Infusion on Pain and Hyperalgesia in Patients Following Groin-Hernia Repair. A Randomized, Placebo-controlled, Double-blind Crossover Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Recent studies have focused on the role of endogenous opioids on central sensitization. Central sensitization is known to be impaired or altered in chronic pain conditions, as fibromyalgia or chronic tension headache. Animal studies have shown reinstatement of mechanical hypersensitivity following naloxone administration after resolution of an injury. This suggests latent sensitization. In the present study, investigators hypothesize that a high-dose target-controlled naloxone infusion (total dose: 3.25 mg/kg) can reinstate pain and hyperalgesia 6-8 weeks after a unilateral primary open groin hernia repair procedure. Investigators aim to show that latent sensitization is present in humans and is modulated by endogenous opioids.

Conditions

Interventions

TypeNameDescription
DRUGTarget-controlled naloxone-infusion
DRUGPlacebo

Timeline

Start date
2015-11-11
Primary completion
2015-12-14
Completion
2018-05-11
First posted
2013-11-25
Last updated
2024-02-22

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01992146. Inclusion in this directory is not an endorsement.